Ignacio Martín Santarelli1,2, Pedro Oscar Manzella1, Julián José Ingold1, Sofía Legnoverde1, María Florencia Falcón1, Sofía Isabel Fernández1, Marcelo José Melero1
1 Hospital de Clínicas “José de San Martín”,
Universidad de Buenos Aires. Ciudad de Buenos Aires, Argentina.
2 E-mail de contacto: isantarelli@fmed.uba.ar
An 18-year-old male recently diagnosed with T-cell acute lymphoblastic leukemia (ALL) was admitted for his second induction chemotherapy treatment with cyclophosphamide, cytarabine, and mercaptopurine. He had no other medical records. He lived with his family in the Buenos Aires suburbs and had 5 cats.
On the 25th day after chemotherapy was initiated, he presented with high fever (39 ºC) and chills, generalized abdominal pain and non-bloody diarrhea.
The patient had a palpable spleen, hepatomegaly and papillitis in the left eye. His BMI was 16 kg/m2. Brain and chest CT, and transesophageal echocardiogram were normal.
Blood analysis revealed hemoglobin 8.8 g/dl, neutrophils 240 x 10³/µl, lymphocytes 490 x 103/µl, platelets 74 x 10³/µl, total bilirubin 0.2 mg/dl, ALAT 72 UI/l, ASAT 26 UI/l, ALP 193 UI/l. Serum protein electrophoresis showed an increased alpha1-fraction (0.33 g/dl) and profound hypogammaglobulinemia (0.4 g/dl). IgA, IgG, and IgM were low (39, 665 and 7 mg/dl respectively).
A few weeks later, he progressively developed a mixed cholestatic-hepatotoxic pattern of liver function tests (total bilirubin: 3.9 mg/dl, direct bilirubin: 3.8 mg/dl, ALAT 938 IU/l, ASAT 885 IU/l, ALP 2,261 IU/l, GGT 331 UI/l). Prothrombin time was normal. Ultrasound reported hepatosplenomegaly, intact extrahepatic bile duct and no signs of thrombosis of the portal vein on Doppler exam. Serologic test results for hepatitis A, B and C were negative.
The patient underwent an exploratory laparoscopy because of sudden worsening of abdominal pain with peritoneal signs. The only finding was mild ascites (66 neutrophils/µl, serum-ascites albumin gradient of 1.6, negative culture). CT scan of the abdomen had reported signs of colitis and periportal oedema. A transjugular liver biopsy was obtained. Hepatic venous pressure gradient was 11 mmHg, compatible with portal hypertension.
The patient persisted with intermittent episodes of abdominal pain, distension, absence of bowel sounds and constipation alternating with diarrhea, along with daily fever, despite neutrophil recovery (1.96 x 103/µl), although leukopenia persisted (2.71 x 103/µl). Upper and lower gastrointestinal endoscopies were performed.
Pathology results (Figure 1) reported non-necrotizing granulomatous inflammation of duodenum and colon with negative cytomegalovirus (CMV) immunostaining, hypocellular bone marrow with 1 non-necrotizing granuloma with negative PAS and Ziehl Neelsen stains; also a few structures suggestive of CMV cytopathic effect were seen. The liver also showed non-necrotizing granulomatous inflammation.
Acid-fast bacillus staining and culture was negative in all tissue samples, including myeloculture, as was GeneXPert® test on the duodenal tissue. PCR tests for CMV, Histoplasma spp. and Bartonella spp. in biopsy materials were negative. Plasmatic CMV viral load was 3,168 copies/ml (viral load log10= 3,5). Serum antibodies for Brucella spp. using Huddleson, Bengal rose test, BPA, SAT, 2-mercaptoethanol agglutination test, complement fixation test, BrucellaGliyco-iELISA and RSAT were negative, as were serum IgG, IgM, and PCR for Bartonella spp.
Figure 1: Nonnecrotizing granulomas with multinucleated giant cells (black arrows) in the duodenum (A - H&E stain, X400), liver (B - H&E stain, X400) and bone marrow
(C – PAS stain, X400).
Cerebrospinal fluid analysis reported an opening pressure of 15 cmH2O, 2 cells/µl, 114 mg/dl of protein and an angiotensin-converting enzyme level < 1.5 U/l (normal < 2.5 U/l). PCR for CMV, Epstein Barr and herpes viruses I and II were negative.
Serum toxoplasmosis, herpes virus, Epstein Barr, herpes viruses I and II, Chagas disease, VDRL, ANA, PR3-ANCA and MPO-ANCA were negative.
In all, 10 sets of blood cultures obtained had no bacterial growth. Lysed-blood cultures, serial serum galactomannans, assay for C. difficile toxin detection, serial fecal sampling, and PCR-molecular detection of Strongyloides stercoralis in fecal sample were negative.
We initially treated this patient with broad-spectrum antimicrobials empirically. Ganciclovir was administered for 30 days, after which CMV viremia was negative. He also received amphotericin, doxycycline, and corticoids as premedication for blood transfusions. With these measures, the fever pattern became relapsing.
Our first diagnostic approach was an immune-deficient or neutropenic fever of unknown origin (FUO)(1), caused by a noncaseating granulomatous disease, responsible for portal hypertension, chronic diarrhea, pancytopenia and papillitis of the left eye.
This patient had several secondary immunodeficiencies: malnutrition, neutropenia, lymphopenia, weakened mucosal barriers caused by chemotherapy, disruption of epithelial and mucosal barriers by central lines and urinary catheters, corticoid use, CMV infection and hypogammaglobulinemia. 65 % of adolescents and young adults with ALL were found to present with hypogammaglobulinemia and an increased frequency of febrile neutropenia episodes and infections, compared with patients with normal IgG levels(2).
Granulomas are organized collections of activated macrophages or histiocytes as the result of a chronic inflammatory process to an antigen or autoantigen that is persistent or difficult to remove(3). Hypogammaglobulinemia, as in common variable immunodeficiency, may be a cause of granulomas(4).
Infections are the commonest causes of disseminated granulomatous disease; in fact, some experts regard an infection as the root cause of all such disorders but that it remains undetected in some(5). A retrospective review of 308 biopsies with non-necrotizing granulomas confirmed sarcoidosis as the leading cause (56 %)(6). Two plausible endemic infectious etiologies in Argentina were unsuccessfully pursued: 1) Tuberculosis, which may also present with non-necrotizing granulomas in immunocompromised patients(7), and 2) Histoplasmosis. The combination of FUO, granulomatous disease, eye involvement and past contact with cats oriented us towards Bartonella spp.infection(8). The most characteristic and common ocular finding of systemic bartonellosis is neuroretinitis (optic disc oedema with macular star)(9), and no evidence of such infectious agent was found. Brucellosis was also ruled out.
We decided to empirically initiate a second-line treatment for tuberculosis, since liver function test was abnormal (ethambutol, levofloxacin, amikacin and meropenem).
Fever defervesced after 5 days, his abdominal manifestations progressively disappeared, leukopenia and neutropenia resolved in a few weeks, and liver function tests eventually normalized. The patient successfully completed the second induction chemotherapy a month after the anti-tubercular drugs were started, and he is currently receiving the maintenance therapy at home. He is a month away from completing a full year of tuberculosis treatment.
The patient was admitted 4 months later for herpes zoster in the left inferior limb. He had been afebrile and without diarrhea.
Unfortunately, we were not able to reach a definitive diagnosis despite a thorough medical history and physical exam, an extensive work-up and numerous efforts. It remains unanswered to us whether this unidentified etiology was successfully treated, or whether it was a self-limiting one, either infectious or non-infectious (for example, sarcoidosis(10)). The fact that all manifestations arose during neutropenia, combined with the profound involvement he exhibited while febrile, strongly suggested an infectious etiology. On the other hand, given our local epidemiology, and the temporal coincidence between the initiation of the antitubercular medications and the patient’s clinical improvement, an incomplete form of tuberculosis remains as the most likely diagnosis to us, even though we were not able to reliably prove it.
The most frequent causes of noncaseating granulomas are presented in Table 1.
TABLE 1 |
|
Etiologies of noncaseating granulomas |
|
A. INFECTIOUS |
B. NONINFECTIOUS |
Mycobacteria |
Berylliosis |
Atypical mycobacteria |
Carcinomatosis |
Tuberculosis (*) |
Drug reaction |
Leprosy |
Eosinophylic granuloma |
Bacteria |
Foreign body reaction |
Bartonella henselae infection |
Granulomatous arteritis |
Brucellosis |
Hypogammaglobulinemia |
Lysteriosis |
Hystiocytosis X |
Melioidosis |
Lymphomas |
Nocardiosis |
Sarcoidosis |
Q-fever (Coxiella brunetti) |
Ultrafiltration |
Spirochetes |
Wegener's granulomatosis |
Syphylis |
|
Yaws (T. pallidum subspecies pertenue) |
|
Fungi |
|
Blastomycosis |
|
Candidiasis |
|
Coccidioidomycosis |
|
Criptococcosis |
|
Histoplasmosis |
|
Mycetoma |
|
Sporothrix schenckii |
|
Protozoa |
|
Leishmaniasis |
|
Virus |
|
Cytomegalovirus |
|
Infectious mononucleosis |
|
Measles, mumps |
|
Actinomyces |
|
Whipple's diesaease |
|
|
|
|
|
Most frequent etiologies of noncaseating granulomas. |
|
Modified from Zumla(11) and James(12). |
|
* In immunocompromised patients (7) |
1.Durack DT, Street AC. Fever of unknown origin—reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.
2.Lange CS, Rahrig A, Althouse SK, Nelson RP, Batra S. Hypogammaglobulinemia in Adolescents and Young Adults with Acute Lymphoblastic Leukemia. J Adolesc Young Adult Oncol. 2020 Dec;9(6):687-692. doi: 10.1089/jayao.2020.0060.
3.Brown I, Kumarasinghe MP. Granulomas in the gastrointestinal tract: deciphering the Pandora's box. Virchows Arch. 2018 Jan;472(1):3-14. doi: 10.1007/s00428-017-2210-3.
4.Timmermans WM, van Laar JA, van Hagen PM, van Zelm MC. Immuno pathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunology. 2016 Dec 16;5(12):e118. doi: 10.1038/cti.2016.75.
5.James DG. A clinic pathological classification of granulomatous disorders. Postgrad Med J. 2000 Aug;76(898):457-65. doi: 10.1136/pmj.76.898.457.
6.Alvarez AB, Lee AS, Mira-Avendano I. Etiologies of consecutive series of non-necrotizing granulomas. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):115-121. doi: 10.36141/svdld.v34i2.5966. 7 Ohshimo S, Guzman J, Costabel U, Bonella F. Differential diagnosis of granulomatous lung disease: clues and pitfalls: Number 4 in the Series "Pathology for the clinician" Edited by Peter Dorfmüller and Alberto Cavazza. Eu rRespir Rev. 2017 Aug 9;26(145):170012. doi: 10.1183/16000617.0012-2017.
7.Caniza MA, Granger DL, Wilson KH, Washington MK, Kordick DL, Frush DP, Blitchington RB. Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity. Clin Infect Dis. 1995 Jun;20(6):1505-11. doi: 10.1093/clinids/20.6.1505.
8.Kahloun R, Abroug N, Ksiaa I, et al. Infectious optic neuropathies: a clinical update. Eye Brain. 2015;7:59-81. doi:10.2147/EB.S69173
9.Ungprasert P, Ryu JH, Matteson EL. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358-375. doi:10.1016/j.mayocpiqo.2019.04.006.
10.Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis. 1996 Jul;23(1):146-58. doi: 10.1093/clinids/23.1.146.
12.Mehta AC, Ali SR. Mnemonic for the differential diagnosis of non-caseating granulomas. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):200-207. doi:10.36141/svdld.v34i2.5674.
Recibido: 2021-08-13 Aceptado: 2021-10-10
DOI:http://dx.doi.org/10.31053/1853.0605.v79.n3.34402
https://creativecommons.org/licenses/by-nc/4.0/
©Universidad Nacional de Córdoba